HLA tests in lung transplant

Role of HLA compatibility and antibodies in lung transplant outcome - HLA tests in lung transplant

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1020210063

Enrollment

200

Registered

2022-01-08

Start date

2021-12-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced pulmonary disease lung transplant, HLA, C1q, mismatch

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo lung transplant between 2022 and 2024

Exclusion criteria

Exclusion criteria: Patients who refuse to provide the consent

Design outcomes

Primary

Measure	Time frame
Short-term mortality after lung transplant (1-2 years post lung transplant)	—

Secondary

Measure	Time frame
The fraction of the development of chronic lung allograft dysfunction (5-6 years post lung transplant) Long-term mortality after lung transplant (5-6 years post lung transplant)	—

Contacts

Public ContactTakashi Hirama

Tohoku University Hospital

takashi.hirama.b5@tohoku.ac.jp+81-22-717-8521

Outcome results